Terry P Yamaguchi

Title: The Innovations of Terry P. Yamaguchi

Introduction

Terry P. Yamaguchi is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of receptor tyrosine kinases, with a focus on proteins expressed in endothelial cells. His work has led to the development of innovative methods for identifying ligands and screening substances that interact with these proteins.

Latest Patents

Terry P. Yamaguchi holds two patents that highlight his groundbreaking research. The first patent is for a novel receptor tyrosine kinase protein and its isoforms, which are expressed in cells of the endothelial lineage. This patent also discloses DNA segments encoding the novel protein and its isoforms. Additionally, it includes methods for identifying ligands capable of binding to the receptor protein and methods for screening agonist or antagonist substances that interact with the protein and a ligand. The second patent similarly focuses on the nucleic acid encoding the tek receptor tyrosine kinase, emphasizing the same innovative methods for ligand identification and screening.

Career Highlights

Terry P. Yamaguchi is affiliated with Mount Sinai Hospital Corporation, where he continues to advance his research in the field of receptor tyrosine kinases. His work has garnered attention for its potential applications in medical science and therapeutic development.

Collaborations

Throughout his career, Terry has collaborated with esteemed colleagues, including Janet Rossant and Daniel J. Dumont. These collaborations have further enriched his research and contributed to the advancement of knowledge in his field.

Conclusion

Terry P. Yamaguchi's contributions to the field of receptor tyrosine kinases are significant and impactful. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and improving medical outcomes.